CG Oncology, Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0000932471-24-000211 | Nov 4, 2024 | — |
| SC 13G | — | 0002012383-24-001588 | Oct 22, 2024 | — |
| 4 | 4 | 0000950170-24-113418 | Oct 8, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113310 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113320 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113314 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113311 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113308 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113304 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113299 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113297 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113290 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-113282 | Oct 7, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-102496 | Aug 30, 2024 | Aug 29, 2024 |
| 144 | — | 0001961863-24-000308 | Aug 29, 2024 | — |
| 144 | — | 0001961863-24-000307 | Aug 29, 2024 | — |
| 144 | — | 0001961863-24-000309 | Aug 29, 2024 | — |
| 144 | — | 0001961863-24-000310 | Aug 29, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-093238 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0000950170-24-093237 | Aug 8, 2024 | — |
| SC 13G | SC 13G | 0001193125-24-182242 | Jul 22, 2024 | — |
| 8-K | 8-K | 0000950170-24-064309 | May 24, 2024 | — |
| 3 | 3 | 0000950170-24-061188 | May 16, 2024 | May 13, 2024 |
| 4 | 4 | 0000950170-24-061276 | May 16, 2024 | May 15, 2024 |
| 8-K | 8-K | 0001193125-24-134805 | May 9, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-056196 | May 9, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001193125-24-130800 | May 3, 2024 | — |
| 4/A | — | 0001415889-24-010609 | Apr 9, 2024 | Jan 29, 2024 |
| SC 13G/A | SC 13G/A | 0001104659-24-045323 | Apr 9, 2024 | — |
| 10-K | 10-K | 0000950170-24-036143 | Mar 26, 2024 | Dec 31, 2023 |
| SC 13G | SC 13G | 0001193125-24-068189 | Mar 14, 2024 | — |
| 8-K | 8-K | 0001193125-24-038506 | Feb 16, 2024 | Feb 15, 2024 |
| SC 13G | SC 13G | 0001193125-24-030117 | Feb 9, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-012374 | Feb 8, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-010557 | Feb 5, 2024 | — |
| SC 13G | SC 13G | 0001193125-24-024118 | Feb 5, 2024 | — |
| 4 | 4 | 0000950170-24-009429 | Jan 31, 2024 | Jan 29, 2024 |
| 4 | — | 0001415889-24-002062 | Jan 31, 2024 | Jan 29, 2024 |
| 4 | 4 | 0000950170-24-009435 | Jan 31, 2024 | Jan 29, 2024 |
| 4 | 4 | 0000950170-24-009432 | Jan 31, 2024 | Jan 29, 2024 |
| 8-K | 8-K | 0001193125-24-018715 | Jan 30, 2024 | Jan 29, 2024 |
| 4 | 4 | 0000950170-24-007962 | Jan 26, 2024 | Jan 24, 2024 |
| S-8 | S-8 | 0001193125-24-016881 | Jan 26, 2024 | — |
| SEC STAFF LETTER | — | 9999999997-24-000220 | Jan 26, 2024 | — |
| 424B4 | 424B4 | 0001193125-24-015534 | Jan 25, 2024 | — |
| 3 | 3 | 0000950170-24-007176 | Jan 24, 2024 | — |
| 3 | 3 | 0000950170-24-007173 | Jan 24, 2024 | — |
| 3 | 3 | 0000950170-24-007171 | Jan 24, 2024 | — |
| 3 | 3 | 0000950170-24-007170 | Jan 24, 2024 | — |
| 3 | 3 | 0000950170-24-007167 | Jan 24, 2024 | — |